Laboratorios Rubió, a family-owned company with 55 years experience, has been recognized for the development, manufacture and marketing of medicines with high therapeutical value for specialists as well as of certain drugs for life-threatening diseases, with long expertise in niche markets. Laboratorios Rubió's determination to meet the health needs of every single patient has led the company to be distinguished as per being pioneer of products targeted to low incidence diseases which affect only to a small number of patients.

  • ES
  • 2015
    On CPHI since
  • 4
  • 100 - 249
Company types
Contact info
  • Calle Industria 29 , Polígono Industria Comte de Sert , 08755 , Castellbisbal, Barcelona, Spain
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from LABORATORIOS RUBIO SA (14)

  • Brivaracetam 10mg/ml oral solution

    Product Brivaracetam 10mg/ml oral solution

    It is used in adults, adolescents and children from 2 years of age.
  • Brivaracetam MR

    Product Brivaracetam MR

    It is used in adults, adolescents and children from 2 years of age. 
  • Methylphenidate hydrochloride IR & MR

    Product Methylphenidate hydrochloride IR & MR

    IR - Treatment for children (over 6 years old) and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 tablets of 5/10/20 mg. Other presentations are also available.MR -  Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactiv...
  • Guanfacine Hydrochloride

    Product Guanfacine Hydrochloride

    Treatment of attention deficit hyperactivity disorder (ADHD)
  • Lisdexamfetamine dimesylate

    Product Lisdexamfetamine dimesylate

    Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
  • Melatonin 1mg/ml oral solution

    Product Melatonin 1mg/ml oral solution

    Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.
  • Melatonin 2mg prolonged -release

    Product Melatonin 2mg prolonged -release

    Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
    Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.
    Modified-release melatonin causes the ...
  • Tadalafil ODT

    Product Tadalafil ODT

    Treatment of erectile dysfunction in adult males. In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required. 
    5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males. 
    The product is not indi...
  • Cholestyramine Resin

    Product Cholestyramine Resin

    Treatment of hypercholesterolaemia: lowering of total and LDL-cholesterol levels in patients with primaryhypercholesterolaemia, including familial hypercholesterolaemia, or secondary as a supplement diet and other treatments, when the response to these measures proves inadequate.Pruritus associated to part...
  • Calcium/Sodium polystyrene sulfonate

    Product Calcium/Sodium polystyrene sulfonate

    Treatment and prevention of hyperkalaemia (hiperpotassemia) in adults and children.• The product has showed efficacy in the reduction of potassium. It is indicated for patients treated with dialysis with hyperkalaemia. Sugar free.Non-systemic absorption. Low cost in daily treatment. Packs Calcium: 15 ...
  • Hydralazine Hydrochloride

    Product Hydralazine Hydrochloride

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
  • Hydroxychloroquine Sulfate

    Product Hydroxychloroquine Sulfate

    ·         Rheumatoid Arthritis (joints inflammation)

    ·         Treatment of non-acute and non-complicate Malaria attacks and prevention of Malaria

    ·       &n...